Answers are grounded in this paper and cite their sources.
Cross-sectional analysis reveals body composition imbalances in adults with type 2 diabetes, indicating significant cardiometabolic risks.
Introduction and Objective: Obesity-related metabolic risk in type 2 DM is driven not only by excess weight but also by unfavorable body composition, particularly visceral adiposity and impaired lean mass distribution. Body composition analysis offers risk stratification beyond BMI. Methods: A cross-sectional analysis was conducted in 474 adults with T2DM using bioelectrical impedance-derived body composition parameters. Measurements included body weight, body mass index (BMI), percent body fat (PBF), visceral fat level (VFL), and skeletal muscle mass (SMM). Distribution characteristics guided parametric and non-parametric interpretation. Pearson and Spearman correlations assessed the relationship between SMM and VFL. Results: Mean body weight was 78.0 ± 14.3 kg, with a mean BMI of 31.0 ± 5.4 kg/m², indicating a predominantly obese cohort. Percent body fat was markedly elevated (41.6 ± 7.5%), consistent across the population. Visceral fat levels clustered in the high-risk range, most frequently between levels 18-20, reflecting significant central adiposity. Despite excess body weight, skeletal muscle mass remained relatively modest (24.6 ± 5.1 kg), suggesting an unfavorable fat-to-muscle balance. Absolute SMM showed no meaningful linear association with visceral adiposity (Pearson r = −0.02), with only a weak monotonic relationship on rank analysis (Spearman ρ = 0.08), indicating disproportionate visceral fat accumulation without proportional lean mass preservation. Conclusion: In adults with T2DM, body composition analysis reveals severe total and visceral adiposity with relatively inadequate skeletal muscle mass, a phenotype not demonstrated by BMI alone. The lack of a meaningful correlation between visceral fat and absolute muscle mass highlights predominant visceral fat accumulation in the absence of proportional skeletal muscle gain. These findings highlight the need for therapeutic strategies that selectively reduce visceral fat while preserving or improving lean mass to mitigate cardiometabolic risk.
No takes yet. Share an insight, caveat, or question.
Patange et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: